Rock Springs Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Rock Springs Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-140,000	Closed	-$7.86M	–	160
2017 Q2	$7.86M	Buy	+140,000	New	+$5.61M	0.4%	75
2016 Q2	–	Sell	-35,000	Closed	-$714K	–	140
2016 Q1	$714K	Buy	+35,000	New	+$1.11M	0.06%	127

Rock Springs Capital Management's PTLA Position: Q3 2020 in Review

Rock Springs Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 2,306,196 shares — an estimated $41.5M sold.

Rock Springs Capital Management first reported a position in PTLA in Q4 2015 and held it in 16 quarters. The position peaked at $41.5M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Rock Springs Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Rock Springs Capital Management sold 2,306,196 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $41.5M.
Rock Springs Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 16 quarters.
Rock Springs Capital Management's Portola Pharmaceuticals, Inc. position peaked at $41.5M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Rock Springs Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.